Loading...
Last update:  December 3, 2017
19:22 +1GMT

Allergenic Molecule  Gal d 3Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.5 - Atopic Dermatitis, Diagnosed2014NetherlandsIgE2112.80020140331, Rockmann H
1.3 - Rhinitis, Diagnosed2013BrazilIgE1010.00020130912, Lacerda Araujo LM
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE1402.86020130111, Ott H
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE960.00020120528, Patelis A
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE995.05020110223, De Knop KJ
6.2 - General Population (Adults)2012SwedenIgE3710.00020120528, Patelis A
4.1.2 - Heterologous Source Sensitized (Symptoms, SPT)2011ChinaIgE1000.00020111214, Zheng YW
5.7.2 - Source Exposed (Provocation Test - Ingestion)2011ItalyIgE2548.00020110505, Egger M
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE164080.46020100301, Scala E
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2010ItalyIgE4613.04020100716, DUrbano LE
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2010.00020091005, Ott H
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE220.00020091121, Ebo DG
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE200.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE370.00020090826, Ebo DG
5.3.1 - Source Exposed (Symptoms, IgE)2008Spain / NetherlandsIgE10100.00020080902, Jacobsen B
6.5 - Occupational Exposure2006SpainIgE240.00020060831, Quirce S
6.5 - Occupational Exposure2006SpainSPT240.00020060831, Quirce S
5.2.1 - Source Exposed (Symptoms, SPT)2001SpainSPT875.000
5.7.2 - Source Exposed (Provocation Test - Ingestion)1996DenmarkIgE3452.900
5.2.1 - Source Exposed (Symptoms, SPT)1987AustraliaIgE1723.500
Developed by
Panservice